Australia’s renewed cervical screening program will halve the incidence of cervical cancer by 2035.
Research we are currently funding:
This project would be a significant step forward in development of personalised treatments and should improve survival for this aggressive cancer.
Impact we've achieved with our research:
A study by Cancer Council NSW has found that rates of vulvar cancer have been increasing significantly from the late 1980s to the mid-2000s.
Kirsty Browne talks about her experience with cancer and becoming a peer support volunteer.
Our researchers are providing crucial evidence to support prevention strategies both in Australia and around the world.
This world-first trial of cervical screening in an HPV-vaccinated population, will further increase our knowledge of Australia's new cervical cancer screening program.
Professor De Fazio’s team is investigating a rare and treatment-resistant subtype of ovarian cancer. Their approach has a better chance of predicting which treatments will work.